Qritive

Ibex Medical Analytics is the pioneer in AI-powered cancer diagnostics in pathology. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision is transforming cancer diagnostics with AI and improving patient care. Pathologists are challenged to provide accurate and timely analysis as the number of tests increases every year. Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that help detect cancer as accurately as a human pathologist. Galen Platform uses algorithms to analyze images, detect and grade cancer in biopsies and point to other findings with high clinical importance, helping pathologists reduce diagnostic error rates and enable a more efficient workflow. Ibex’s Galen™ Prostate and Galen™ Breast are the first-ever AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases.

Concentriq, our AI-powered software platform sits at the intersection of digital and computational pathology, where functionality needed to carry out routine pathology operations connects with powerful AI applications to accelerate breakthroughs and improve patient outcomes. Laboratories worldwide recognize the challenges we all face today—a rising cancer burden, a shortage of pathologists, declining reimbursements, and the demands to rapidly modernize. However, with one billion pathology slides per year set to go digital, creating vast amounts of new data and information, the time to seize this moment is now. Digital pathology is giving today’s forward-thinking pathology organizations the means to overcome our collective challenges and fundamentally transform how we work and contribute to medicine and patient care.